Background: Obesity is a modifiable risk factor for breast cancer in postmenopausal females. Aim: This study was conducted to investigate the association between obesity and breast cancer risk among Egyptian postmenopausal females in Alexandria. Subjects: This study included 100 Egyptian postmenopausal females, 50 of them were breast cancer patients with mean age (54.6 years± 9.6) and the other 50 were controls with mean age (53.9 years± 2.5). Methods: Standardized questionnaires concerning age, anthropometric, menstrual and reproductive information, family history of breast cancer in first degree relatives and history of hypertension were completed by the same researcher. Fasting blood samples were withdrawn from all participating females to separate sera in which total estradiol, insulin and glucose levels were measured. Results: Univariate analysis showed that age at presentation ≥ 60 years, delayed menopause > 50 years, family history of breast cancer in first degree relatives, oral contraceptive use, body mass index (BMI), waist circumference (WC) and serum levels of total estradiol were found to be significantly associated with higher risk of breast cancer in postmenopausal females. Multivariate logistic regression analysis showed that old age at presentation ≥ 60 years and late menopause >50 years were the strongest risk factors, while oral contraceptive use and increased WC >100 cm showed border line significance. Conclusion: Based on the results obtained from this study, we advice Egyptian postmenopausal females of Alexandria to control weight by decreasing dietary caloric intake, maintain physical activity and breast self-examination continuously in order to decrease the risk of breast carcinoma.
Background: Chronic placental insufficiency is a common condition that affects fetal growth and wellbeing. The response of the fetus to such stress depends on time and degree of placental affection. The acute placental insufficiency rapidly affects the fetal movements, amount of liquor and might lead to fetal demise while the chronic placental insufficiency is more deciduous and affects fetal weight and develops fetal growth restriction more slowly. The prophylaxis against the development of chronic placental insufficiency is more effective to protect growth and avoid perinatal morbidities and moralities. Aim: Evaluation of 2 new ultrasound signs (tent like placenta and turbid liquor) to predict early placental insufficiency Materials and Methods: One hundred pregnant women with gestational age between 16 weeks till 28 weeks were included in the study. This cohort of women with singleton pregnancy was evaluated by detailed ultrasound scanning to document gestational age, amniotic fluid index, cerebroplacental ratio (CPR), exclusion of congenital anomalies and other routine ultrasound scanning items. This cohort was divided into two groups, group one was the group with placental tenting and/or turbid liquor while group two was the group with no evidence of placental tenting or turbid liquor. Results: Documentation of all relevant demographic data was done. The follow up was done every two weeks in all cases unless patients complained of decreased or absent fetal movement, passage of liquor, passage of blood. Spontaneous labour was allowed in primigravidae and elective cesarean section in Cases with previous c-section at completed 38 weeks of gestation was done unless one or more of the following signs had appeared that indicated the need for emergency delivery which were : abnormal low CPR less than 0.76, severe oligohydramnios, biophysical profile equal to or less than 4/8, abnormal cardiotocogram and fetal distress. The duration from the beginning of the study and documentation of the new studied signs in the placenta and turbid liquor till the development of placental insufficiency was calculated in weeks. All complications or adverse events were documented in both groups. Conclusions: Both new signs were associated with increased risk for development of chronic placental insufficiency and can be used as predictors for evaluation of all pregnant women in the second trimester.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.